Products

Acitretin is a retinoid used in the treatment of severe psoriasis and other skin disorders in adults.

Adcetris (brentuximab vedotin) is an antibody-drug conjugate used to treat relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Blinatumomab

Monoclonal antibody
Type	Bi-specific T-cell engager
Source	Mouse
Target	CD19, CD3
Clinical data
Trade names	Blincyto
Synonyms	AMG103, MT103
License data	EU EMA: by INN
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	intravenous
ATC code	L01XC19 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Bioavailability	100% (IV)
Metabolism	degradation into small peptides and amino acids
Elimination half-life	2.11 hours
Excretion	urine (negligible)
Identifiers
CAS Number	853426-35-4
DrugBank	DB09052
ChemSpider	none
UNII	4FR53SIF3A
KEGG	D09325
Chemical and physical data
Formula	C2367H3577N649O772S19
Molar mass	54.1 kg/mol
(what is this?)  (verify)

Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.

Foscavir  (foscarnet sodium) is an antiviral agent. Foscavir  (foscarnet sodium) is used to control cytomegalovirus (CMV) retinitis in HIV patients and to treat herpes infections (HSV) that do not respond to treatment with acyclovir (acyclovir-resistant).

Side Effects: Herceptin (trastuzumab) is a cancer medication that interferes with the growth and spread of cancer cells in the body. Herceptin is used to treat certain types of breast cancer or stomach cancer. Other cancer medicines are sometimes used in combination with Herceptin.

Albumin (Human)  is a sterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature controlled fractionation according to the Cohn process.

Tolvaptan (Trade names: Jinarc and Samsca) is an aquaretic drug that functions as a selective, competitivevasopressin receptor 2 antagonist.

Trastuzumab emtansine also known as ado-trastuzumab emtansine and sold under the trade name Kadcyla, is an antibody-drug conjugate consisting of the monoclonal antibody.

Lenvima (generic name Lenvatinib) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. Lenvima was developed by Eisai and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.

Ocrevus (ocrelizumab) is a prescription medicine used to treat adults with relapsing or primary progressive forms of multiple sclerosis.

OCTAGAM 10% is an immune globulin intravenous (human) liquid preparation indicated for the treatment of chronic immune thrombocytopenic purpura (ITP) in adults.

Oncaspar (Generic Pegaspargase ) is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation.

Oxsoralen 10 mg capsules are used for the treatment of severe and severe cases of psoriasis as part of a PUVA therapy (PUVA = psoralen + UV-A radiation) in adults and adolescents from 12 years.

Revlimid (Lenalidomide) is a derivative of thalidomide introduced in 2004. Revlimid (Lenalidomide) is use for various indications:

Tecentriq (Atezolizumab)  is a fully humanized, engineered monoclonal antibody of IgG1isotype against the protein programmed cell death-ligand 1 (PD-L1).

Tepadina (Thiotepa) is an alkylating agent used with other medicines in the conditioning regimen before hematopoietic stem cell transplantation (HSCT).

Certican is used to treat adult patients who have had kidney, heart or liver transplants. It helps to prevent your body from rejecting the transplanted organ.

ALIMTA (pemetrexed for injection) is a folate analog metabolic inhibitor. ALIMTA is a sterile white-to-light yellow or green-yellow lyophilized powder in single-dose vials to be reconstituted for intravenous infusion. Each 100-mg vial of ALIMTA contains 100 mg pemetrexed (equivalent to 139.8 mg pemetrexed disodium heptahydrate) and 106 mg mannitol. Each 500-mg vial of ALIMTA contains 500 mg pemetrexed (equivalent to 699 mg pemetrexed disodium heptahydrate) and 500 mg mannitol. Hydrochloric acid and/or sodium hydroxide may have been added to adjust pH.

Pembrolizumab is the generic name for the trade drug name Keytruda.

Alkeran is the trade name for Melphalan.

Venetoclax, sold under the trade name Venclexta and Venclyxto, is a medication used to treat chronic lymphocytic leukemia in those who have failed first line treatment.

Copaxone (Glatiramer Acetate) is an immunomodulator medication currently used to treat multiple sclerosis. Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability.

Cariprazine, sold under the brand names Vraylar in the United States and Reagila in Europe, is an atypical antipsychotic which is used in the treatment of schizophrenia and bipolar mania.

CRYSVITA is a fibroblast growth factor 23 (FGF23) blocking antibody indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older.